Moreover, specific FAK and PI3K inhibitors reduced SOX11-mediated cell migration and stromal interactions with a reversion of cell-adhesion-mediated drug resistance to the same level of SOX11-negative MCL. This evidence concerns the gene PTK2 and mantle cell lymphoma.